Meiji Yasuda Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Sell |
|
|||||
|
2025
Q1 | $850K | Sell |
|
|||||
|
2024
Q4 | $825K | Sell |
|
|||||
|
2024
Q3 | $885K | Sell |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $603K | Sell |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $1.34M | Buy |
|
|||||
|
2023
Q2 | $660K | Sell |
|
|||||
|
2023
Q1 | $749K | Sell |
|
|||||
|
2022
Q4 | $1.59K | Sell |
|
|||||
|
2022
Q3 | $1.31M | Buy |
|
|||||
|
2022
Q2 | $1.15M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $709K | Hold |
|
|||||
|
2021
Q2 | $765K | Sell |
|
|||||
|
2021
Q1 | $705K | Buy |
|
|||||
|
2020
Q4 | $738K | Buy |
|
|||||
|
2020
Q3 | $324K | Sell |
|
|||||
|
2020
Q2 | $690K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $202K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $205K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $204K | Buy |
|